Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.

[1]  E. Cohen,et al.  Significant increase in end-stage renal disease after hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[2]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[3]  D. Scheinberg,et al.  Mitigation of radiation nephropathy after internal α-particle irradiation of kidneys , 2006 .

[4]  John P Klein,et al.  Modelling competing risks in cancer studies , 2006, Statistics in medicine.

[5]  R. Storb,et al.  Chronic Kidney Disease Following Non‐Myeloablative Hematopoietic Cell Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[7]  E. Cohen,et al.  ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy. , 2003, Current pharmaceutical design.

[8]  M. Christian,et al.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Krämer,et al.  Renal failure after bone marrow transplantation , 2001, The Lancet.

[10]  E. Cohen,et al.  Radiation nephropathy after bone marrow transplantation. , 2000, Kidney international.

[11]  C. Klabunde,et al.  Factors influencing enrollment in clinical trials for cancer treatment. , 1999, Southern medical journal.

[12]  C. Kabler-Babbitt,et al.  End-Stage Renal Disease (ESRD)after Bone Marrow Transplantation: Poor Survival Compar ed to Other Causes of ESRD , 1998, Nephron.

[13]  E. Cohen,et al.  Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation , 1997, Bone Marrow Transplantation.

[14]  E. Cohen,et al.  Successful brief captopril treatment in experimental radiation nephropathy. , 1997, The Journal of laboratory and clinical medicine.

[15]  E. Cohen,et al.  Noncontinuous use of angiotensin converting enzyme inhibitors in the treatment of experimental bone marrow transplant nephropathy , 1997, Bone Marrow Transplantation.

[16]  R. Zager.  Acute renal failure in the setting of bone marrow transplatation , 1994 .

[17]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[18]  H. Prentice,et al.  Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? , 1988, Bone marrow transplantation.

[19]  D. Scheinberg,et al.  Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys. , 2006, International journal of radiation oncology, biology, physics.

[20]  E. Deconinck,et al.  Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation. , 2005, Haematologica.

[21]  R. Zager.  Acute renal failure in the setting of bone marrow transplantation. , 1994, Kidney international.

[22]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[23]  C. G. Becker,et al.  Clinical course of late-onset bone marrow transplant nephropathy. , 1993, Nephron.